This study has merged into the BOS study. Please click here to be taken to the BOS study page for details and information on how to participate.  
Current Role Assistant Research Scientist, Bastyr University Research Institute Research Survey of Cannabis Use This questionnaire is designed to probe the natural history of this phenomenon of a self-administered herb/drug. Data from this...
Detailed Description: This case-control study will recruit individuals with a diagnosis of MS and healthy controls. Individuals will be asked to come to Bastyr Clinical Research Center for a single study visit, at which time dietary intake,...
TO PARTICIPATE First: Download and read the Participant Information Sheet. (PDF) Second: Fill out this online survey Project Overview Multiple sclerosis is often said to be an incurable, progressive, and degenerative disease.  It is our...
Project Goals This is a Phase I study seeking to determine whether intranasal glutathione (nasal spray) is safe and tolerable. Participants will be asked to administer the nasal spray...
This study explores if changes in serum iron levels and iron binding proteins are associated with an increased risk of developing Parkinson's disease. This study focuses on iron changes due to the presence of particular phenotypes, or lifestyle...
This study is a survey of practicing Naturopathic Doctors (NDs) and ND students investigating health promotion and prevention both personally and professionally. Participants complete an...
This is a Phase I randomized 2-arm study. After screening, informed consent and randomization, participants will either first complete a medically-monitored 3-week sauna-based detoxification program followed by a 3-week observation period (and a...
Bastyr Integrative Oncolgy Reserch Center (BIORC) is actively recruiting participants with colon cancer at any stage to take part in an observational research study. By studying how cancer reacts when treated with naturopathic medicine, traditional...
  BACKGROUND: Although the Women's Health Initiative (WHI) trial of estrogen plus progestin in postmenopausal women identified more overall health risks than benefits among women in the hormone group, the use of estrogen plus progestin was...